Home
>
US Stocks
>
Geron Corp.
Geron Corp.
GERN

Geron Corp.

$1.425.19%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
1.42
Today Low/High
1.41 / 1.44
52 Week Low/High
$1.2 / $2.36
P/E ratio
-4.6823
Market Cap
$407.77M

Company Details

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.
Organisation
Geron Corp.
Headquaters
Foster City, California, US
Employees
54
Industry
Health Technology
CEO
John Scarlett

Discover more

Frequently Asked Questions

What is Geron Corp. share price today

Can Indians buy Geron Corp. shares?

How can I buy Geron Corp. shares from India?

Can Fractional shares of Geron Corp. be purchased?

What are the documents required to start investing in Geron Corp. stocks?

We are a SEBI registered investement advisor